Chen, A.; Zheng, Z.-Y.; Anurag, M.; Elkhanany, A.; Chen, N.C.; Chang, E.C.
CDK4/6 Inhibitors in Breast Cancer—Who Should Receive Them? Int. J. Mol. Sci. 2025, 26, 10322.
https://doi.org/10.3390/ijms262110322
AMA Style
Chen A, Zheng Z-Y, Anurag M, Elkhanany A, Chen NC, Chang EC.
CDK4/6 Inhibitors in Breast Cancer—Who Should Receive Them? International Journal of Molecular Sciences. 2025; 26(21):10322.
https://doi.org/10.3390/ijms262110322
Chicago/Turabian Style
Chen, Anran, Ze-Yi Zheng, Meenakshi Anurag, Ahmed Elkhanany, Natalie C. Chen, and Eric C. Chang.
2025. "CDK4/6 Inhibitors in Breast Cancer—Who Should Receive Them?" International Journal of Molecular Sciences 26, no. 21: 10322.
https://doi.org/10.3390/ijms262110322
APA Style
Chen, A., Zheng, Z.-Y., Anurag, M., Elkhanany, A., Chen, N. C., & Chang, E. C.
(2025). CDK4/6 Inhibitors in Breast Cancer—Who Should Receive Them? International Journal of Molecular Sciences, 26(21), 10322.
https://doi.org/10.3390/ijms262110322